High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events

The current consensus recommendation papers dealing with the unique requirements for the analytical validation of assays performed by flow cytometry address the validation of sensitivity (both analytical and functional) only in general terms. In this paper, a detailed approach for designing and vali...

Full description

Saved in:
Bibliographic Details
Published in:Cytometry. Part B, Clinical cytometry Clinical cytometry, 2021-01, Vol.100 (1), p.42-51
Main Authors: Sommer, Ulrike, Eck, Steven, Marszalek, Laura, Stewart, Jennifer J., Bradford, Jolene, McCloskey, Thomas W., Green, Cherie, Vitaliti, Alessandra, Oldaker, Teri, Litwin, Virginia
Format: Article
Language:English
Subjects:
Assaying
Best practice
design control
Design optimization
Equipment Design
Flow cytometry
Flow Cytometry - instrumentation
flow cytometry validation
high‐sensitivity flow cytometric assay
Humans
LLOQ
Mathematical analysis
rare events
Sensitivity analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3
cites cdi_FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3
container_end_page 51
container_issue 1
container_start_page 42
container_title Cytometry. Part B, Clinical cytometry
container_volume 100
creator Sommer, Ulrike
Eck, Steven
Marszalek, Laura
Stewart, Jennifer J.
Bradford, Jolene
McCloskey, Thomas W.
Green, Cherie
Vitaliti, Alessandra
Oldaker, Teri
Litwin, Virginia
description The current consensus recommendation papers dealing with the unique requirements for the analytical validation of assays performed by flow cytometry address the validation of sensitivity (both analytical and functional) only in general terms. In this paper, a detailed approach for designing and validating the sensitivity of rare event methods is described. The impact of panel design and optimization on the lower limit of quantification (LLOQ) and suggestions for reporting data near, or below, the LLOQ are addressed. This paper serves to provide best practices for the development, optimization, and analytical validation of flow cytometric assays designed to assess rare events. Note that this paper does not discuss clinical sensitivity validation, which addresses the positive and negative predictive value of the test result.
doi_str_mv 10.1002/cyto.b.21949
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2443881592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2443881592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3</originalsourceid><addsrcrecordid>eNp90btuHCEUBmAUxYpv6VJHSGlSeNfAwAykc1ZObMmSJcsuUiGGi4PFDg6wa02XMqWfMU8SZtd2kcIFAh0-folzAPiA0RwjRI71WOK8nxMsqHgD9jBjZEYF696-nKnYBfs53yHUMNp278BuQwRFgnZ74M-Zv_359_djtkP2xa99GaEL8QFOsUtbktdQ5azG_AUuYjXGJlV8PUEXEzQ2-9sB6jiUFANUg6lLhbF4rQJcq-DNRm9wfTsU7-rVphQdvFLJQruu5XwIdpwK2b5_2g_AzbfT68XZ7OLy-_ni5GKmKSJixhHjTcMarY3QHDtCsePIqZ4q0xqCMSWdaInrWtQ62-CWGk457TtLGWfONAfg8zb3PsVfK5uLXPqsbQhqsHGVJaG04RwzQSr99B-9i6tUvzepTtRWCjSpo63SKeacrJP3yS9VGiVGcpqQnFope7mZUOUfn0JX_dKaF_w8kgroFjz4YMdXw-Tix_Xl123uP0bqoIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2479467902</pqid></control><display><type>article</type><title>High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events</title><source>Wiley</source><creator>Sommer, Ulrike ; Eck, Steven ; Marszalek, Laura ; Stewart, Jennifer J. ; Bradford, Jolene ; McCloskey, Thomas W. ; Green, Cherie ; Vitaliti, Alessandra ; Oldaker, Teri ; Litwin, Virginia</creator><creatorcontrib>Sommer, Ulrike ; Eck, Steven ; Marszalek, Laura ; Stewart, Jennifer J. ; Bradford, Jolene ; McCloskey, Thomas W. ; Green, Cherie ; Vitaliti, Alessandra ; Oldaker, Teri ; Litwin, Virginia</creatorcontrib><description>The current consensus recommendation papers dealing with the unique requirements for the analytical validation of assays performed by flow cytometry address the validation of sensitivity (both analytical and functional) only in general terms. In this paper, a detailed approach for designing and validating the sensitivity of rare event methods is described. The impact of panel design and optimization on the lower limit of quantification (LLOQ) and suggestions for reporting data near, or below, the LLOQ are addressed. This paper serves to provide best practices for the development, optimization, and analytical validation of flow cytometric assays designed to assess rare events. Note that this paper does not discuss clinical sensitivity validation, which addresses the positive and negative predictive value of the test result.</description><identifier>ISSN: 1552-4949</identifier><identifier>EISSN: 1552-4957</identifier><identifier>DOI: 10.1002/cyto.b.21949</identifier><identifier>PMID: 32940947</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Assaying ; Best practice ; design control ; Design optimization ; Equipment Design ; Flow cytometry ; Flow Cytometry - instrumentation ; flow cytometry validation ; high‐sensitivity flow cytometric assay ; Humans ; LLOQ ; Mathematical analysis ; rare events ; Sensitivity analysis</subject><ispartof>Cytometry. Part B, Clinical cytometry, 2021-01, Vol.100 (1), p.42-51</ispartof><rights>2020 International Clinical Cytometry Society</rights><rights>2020 International Clinical Cytometry Society.</rights><rights>2021 International Clinical Cytometry Society</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3</citedby><cites>FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32940947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sommer, Ulrike</creatorcontrib><creatorcontrib>Eck, Steven</creatorcontrib><creatorcontrib>Marszalek, Laura</creatorcontrib><creatorcontrib>Stewart, Jennifer J.</creatorcontrib><creatorcontrib>Bradford, Jolene</creatorcontrib><creatorcontrib>McCloskey, Thomas W.</creatorcontrib><creatorcontrib>Green, Cherie</creatorcontrib><creatorcontrib>Vitaliti, Alessandra</creatorcontrib><creatorcontrib>Oldaker, Teri</creatorcontrib><creatorcontrib>Litwin, Virginia</creatorcontrib><title>High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events</title><title>Cytometry. Part B, Clinical cytometry</title><addtitle>Cytometry B Clin Cytom</addtitle><description>The current consensus recommendation papers dealing with the unique requirements for the analytical validation of assays performed by flow cytometry address the validation of sensitivity (both analytical and functional) only in general terms. In this paper, a detailed approach for designing and validating the sensitivity of rare event methods is described. The impact of panel design and optimization on the lower limit of quantification (LLOQ) and suggestions for reporting data near, or below, the LLOQ are addressed. This paper serves to provide best practices for the development, optimization, and analytical validation of flow cytometric assays designed to assess rare events. Note that this paper does not discuss clinical sensitivity validation, which addresses the positive and negative predictive value of the test result.</description><subject>Assaying</subject><subject>Best practice</subject><subject>design control</subject><subject>Design optimization</subject><subject>Equipment Design</subject><subject>Flow cytometry</subject><subject>Flow Cytometry - instrumentation</subject><subject>flow cytometry validation</subject><subject>high‐sensitivity flow cytometric assay</subject><subject>Humans</subject><subject>LLOQ</subject><subject>Mathematical analysis</subject><subject>rare events</subject><subject>Sensitivity analysis</subject><issn>1552-4949</issn><issn>1552-4957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp90btuHCEUBmAUxYpv6VJHSGlSeNfAwAykc1ZObMmSJcsuUiGGi4PFDg6wa02XMqWfMU8SZtd2kcIFAh0-folzAPiA0RwjRI71WOK8nxMsqHgD9jBjZEYF696-nKnYBfs53yHUMNp278BuQwRFgnZ74M-Zv_359_djtkP2xa99GaEL8QFOsUtbktdQ5azG_AUuYjXGJlV8PUEXEzQ2-9sB6jiUFANUg6lLhbF4rQJcq-DNRm9wfTsU7-rVphQdvFLJQruu5XwIdpwK2b5_2g_AzbfT68XZ7OLy-_ni5GKmKSJixhHjTcMarY3QHDtCsePIqZ4q0xqCMSWdaInrWtQ62-CWGk457TtLGWfONAfg8zb3PsVfK5uLXPqsbQhqsHGVJaG04RwzQSr99B-9i6tUvzepTtRWCjSpo63SKeacrJP3yS9VGiVGcpqQnFope7mZUOUfn0JX_dKaF_w8kgroFjz4YMdXw-Tix_Xl123uP0bqoIw</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Sommer, Ulrike</creator><creator>Eck, Steven</creator><creator>Marszalek, Laura</creator><creator>Stewart, Jennifer J.</creator><creator>Bradford, Jolene</creator><creator>McCloskey, Thomas W.</creator><creator>Green, Cherie</creator><creator>Vitaliti, Alessandra</creator><creator>Oldaker, Teri</creator><creator>Litwin, Virginia</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>202101</creationdate><title>High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events</title><author>Sommer, Ulrike ; Eck, Steven ; Marszalek, Laura ; Stewart, Jennifer J. ; Bradford, Jolene ; McCloskey, Thomas W. ; Green, Cherie ; Vitaliti, Alessandra ; Oldaker, Teri ; Litwin, Virginia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Assaying</topic><topic>Best practice</topic><topic>design control</topic><topic>Design optimization</topic><topic>Equipment Design</topic><topic>Flow cytometry</topic><topic>Flow Cytometry - instrumentation</topic><topic>flow cytometry validation</topic><topic>high‐sensitivity flow cytometric assay</topic><topic>Humans</topic><topic>LLOQ</topic><topic>Mathematical analysis</topic><topic>rare events</topic><topic>Sensitivity analysis</topic><toplevel>online_resources</toplevel><creatorcontrib>Sommer, Ulrike</creatorcontrib><creatorcontrib>Eck, Steven</creatorcontrib><creatorcontrib>Marszalek, Laura</creatorcontrib><creatorcontrib>Stewart, Jennifer J.</creatorcontrib><creatorcontrib>Bradford, Jolene</creatorcontrib><creatorcontrib>McCloskey, Thomas W.</creatorcontrib><creatorcontrib>Green, Cherie</creatorcontrib><creatorcontrib>Vitaliti, Alessandra</creatorcontrib><creatorcontrib>Oldaker, Teri</creatorcontrib><creatorcontrib>Litwin, Virginia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cytometry. Part B, Clinical cytometry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sommer, Ulrike</au><au>Eck, Steven</au><au>Marszalek, Laura</au><au>Stewart, Jennifer J.</au><au>Bradford, Jolene</au><au>McCloskey, Thomas W.</au><au>Green, Cherie</au><au>Vitaliti, Alessandra</au><au>Oldaker, Teri</au><au>Litwin, Virginia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events</atitle><jtitle>Cytometry. Part B, Clinical cytometry</jtitle><addtitle>Cytometry B Clin Cytom</addtitle><date>2021-01</date><risdate>2021</risdate><volume>100</volume><issue>1</issue><spage>42</spage><epage>51</epage><pages>42-51</pages><issn>1552-4949</issn><eissn>1552-4957</eissn><abstract>The current consensus recommendation papers dealing with the unique requirements for the analytical validation of assays performed by flow cytometry address the validation of sensitivity (both analytical and functional) only in general terms. In this paper, a detailed approach for designing and validating the sensitivity of rare event methods is described. The impact of panel design and optimization on the lower limit of quantification (LLOQ) and suggestions for reporting data near, or below, the LLOQ are addressed. This paper serves to provide best practices for the development, optimization, and analytical validation of flow cytometric assays designed to assess rare events. Note that this paper does not discuss clinical sensitivity validation, which addresses the positive and negative predictive value of the test result.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32940947</pmid><doi>10.1002/cyto.b.21949</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-4949
ispartof Cytometry. Part B, Clinical cytometry, 2021-01, Vol.100 (1), p.42-51
issn 1552-4949
1552-4957
language eng
recordid cdi_proquest_miscellaneous_2443881592
source Wiley
subjects Assaying
Best practice
design control
Design optimization
Equipment Design
Flow cytometry
Flow Cytometry - instrumentation
flow cytometry validation
high‐sensitivity flow cytometric assay
Humans
LLOQ
Mathematical analysis
rare events
Sensitivity analysis
title High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A35%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%E2%80%90sensitivity%20flow%20cytometric%20assays:%20Considerations%20for%20design%20control%20and%20analytical%20validation%20for%20identification%20of%20Rare%20events&rft.jtitle=Cytometry.%20Part%20B,%20Clinical%20cytometry&rft.au=Sommer,%20Ulrike&rft.date=2021-01&rft.volume=100&rft.issue=1&rft.spage=42&rft.epage=51&rft.pages=42-51&rft.issn=1552-4949&rft.eissn=1552-4957&rft_id=info:doi/10.1002/cyto.b.21949&rft_dat=%3Cproquest_cross%3E2443881592%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4029-80583353ccd9c81f241f80fab4ad6d211427962f7606fe3164d8484b7e4585fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2479467902&rft_id=info:pmid/32940947&rfr_iscdi=true